Randomized Phase II Trial of Fluorouracil and Folinic Acid With or Without Liposomal Irinotecan (ONIVYDE) for Patients With Metastatic Biliary Tract Cancer Which Progressed Following Gemcitabine Plus Cisplatin
Phase of Trial: Phase II
Latest Information Update: 26 Sep 2019
Price : $35 *
At a glance
- Drugs Fluorouracil (Primary) ; Folic acid (Primary) ; Irinotecan (Primary)
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- Acronyms NIFTY
- 26 Sep 2019 According to an Ipsen media release, data will be presented at the European Society for Medical Oncology (ESMO) Congress 2019.
- 02 Oct 2018 Status changed from not yet recruiting to recruiting.
- 16 May 2018 New trial record